VBI Vaccines Inc expected to post a loss of 8 cents a share - Earnings Preview

VBI Vaccines

04/11/2022 18:07

* VBI Vaccines Inc  VBIV.OQ   VBIV.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 7
(estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 1,108.4% increase in revenue to $1.293 million from $107
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for VBI Vaccines Inc is
for a
loss of 8 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $6​, above​ its last closing price of $0.67. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.07       -0.07      -0.18     Missed  -157.1
 Mar. 31 2022  -0.08       -0.08      -0.08     Met     0
 Dec. 31 2021              -0.07      -0.07     Met     4.5​
 Sep. 30 2021  -0.07       -0.07      -0.06     Beat    14.3
 ​​Jun.        -0.06       -0.06      -0.07     Missed  -23.5
 30 2021                                                
 Mar. 31 2021  -0.06       -0.06      -0.07     Missed  -16.7​
 Dec. 31 2020  -0.06       -0.06      -0.06     Met     -3.4
 Sep. 30 2020  -0.04       -0.04      -0.06     Missed  -33.3
 This summary was machine generated November 4 at 18:07 GMT.  All
figures in US dollars  unless otherwise stated